https://prabadinews.com/
Dynavax’s Z-1018 Shingles Vaccine Candidate Shows Promising Immune Response and Safety in Early Trial

A novel shingles vaccine candidate demonstrated positive topline results of antibody and CD4⁺ T cell vaccine responses.

administrator

Related Articles